Free Trial

The Hanover Insurance Group (THG) Financials

The Hanover Insurance Group logo
$176.06 +1.89 (+1.09%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$175.95 -0.11 (-0.06%)
As of 05/30/2025 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for The Hanover Insurance Group

Annual Income Statements for The Hanover Insurance Group

This table shows The Hanover Insurance Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
426 35 116 423 359 425 391 186 155 332
Consolidated Net Income / (Loss)
426 35 116 423 359 425 391 186 155 332
Net Income / (Loss) Continuing Operations
425 34 117 420 362 429 239 216 67 331
Total Pre-Tax Income
538 41 144 521 445 522 283 293 66 439
Total Revenue
6,195 5,973 5,500 5,075 4,801 4,747 4,464 4,228 4,173 4,988
Net Interest Income / (Expense)
-34 -34 -34 -34 -37 -38 -45 -45 -51 -61
Total Interest Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense
34 34 34 34 37 38 45 45 51 61
Long-Term Debt Interest Expense
34 34 34 34 37 38 45 45 51 61
Total Non-Interest Income
6,229 6,007 5,534 5,109 4,838 4,784 4,510 4,274 4,225 5,048
Other Service Charges
28 31 27 24 27 26 23 23 23 31
Net Realized & Unrealized Capital Gains on Investments
288 313 255 315 283 286 237 271 413 313
Premiums Earned
5,913 5,663 5,252 4,770 4,527 4,475 4,254 3,980 3,790 4,705
Total Non-Interest Expense
5,675 5,926 5,292 4,672 4,353 4,331 4,139 3,935 4,107 4,548
Property & Liability Insurance Claims
3,757 4,135 3,623 3,134 2,845 2,866 2,725 2,580 2,546 2,884
Other Operating Expenses
690 608 574 555 557 539 522 510 730 631
Amortization Expense
1,222 1,176 1,093 983 951 927 892 841 804 1,033
Impairment Charge
5.80 7.70 1.90 - - - - 5.60 27 -
Nonoperating Income / (Expense), net
14 -5.60 -63 119 - 107 -43 - - -
Income Tax Expense
113 7.60 27 101 83 93 44 77 -1.00 109
Net Income / (Loss) Discontinued Operations
0.70 1.80 -0.80 2.80 -3.30 -3.90 152 -30 -1.00 0.70
Basic Earnings per Share
$11.85 $0.99 $3.26 $11.78 $9.52 $10.62 $9.21 $4.38 $3.63 $7.55
Weighted Average Basic Shares Outstanding
35.90M 35.70M 35.60M 35.90M 37.70M 40M 42.40M 42.50M 42.80M 43.90M
Diluted Earnings per Share
$11.70 $0.98 $3.21 $11.60 $9.42 $10.46 $9.09 $4.33 $3.59 $7.40
Weighted Average Diluted Shares Outstanding
36.40M 36.10M 36.10M 36.40M 38.10M 40.60M 43M 43M 43.20M 44.80M
Weighted Average Basic & Diluted Shares Outstanding
35.93M 35.82M 35.60M 35.48M 36.39M 38.45M 40.57M 42.50M 42.70M 43.90M

Quarterly Income Statements for The Hanover Insurance Group

This table shows The Hanover Insurance Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
128 168 102 41 116 108 8.60 -69 -12 -12 0.50
Consolidated Net Income / (Loss)
128 168 102 41 116 108 8.60 -69 -12 -12 0.50
Net Income / (Loss) Continuing Operations
128 167 102 40 116 107 8.20 -70 -12 -12 0.60
Total Pre-Tax Income
160 212 130 51 145 150 -0.90 -91 -18 -15 0.50
Total Revenue
1,594 1,583 1,546 1,531 1,536 1,519 1,513 1,499 1,442 1,518 1,366
Net Interest Income / (Expense)
-8.50 -8.50 -8.50 -8.60 -8.50 -8.50 -8.50 -8.60 -8.50 -8.60 -8.50
Total Interest Income
0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense
8.50 8.50 8.50 8.60 8.50 8.50 8.50 8.60 8.50 8.60 8.50
Long-Term Debt Interest Expense
8.50 8.50 8.50 8.60 8.50 8.50 8.50 8.60 8.50 8.60 8.50
Total Non-Interest Income
1,602 1,591 1,554 1,539 1,545 1,527 1,522 1,507 1,451 1,456 1,395
Other Service Charges
6.40 6.40 6.70 7.60 7.30 7.60 7.40 7.80 8.00 7.10 7.00
Net Realized & Unrealized Capital Gains on Investments
87 73 68 58 88 64 83 88 78 70 73
Premiums Earned
1,509 1,512 1,479 1,473 1,449 1,440 1,431 1,412 1,380 1,364 1,331
Other Non-Interest Income
0.00 - - - 0.30 - - - -15 - -16
Total Non-Interest Expense
1,435 1,370 1,428 1,480 1,397 1,376 1,509 1,588 1,453 1,486 1,357
Property & Liability Insurance Claims
955 861 954 1,008 935 916 1,062 1,140 1,017 1,051 940
Other Operating Expenses
165 196 165 166 163 156 151 154 147 150 141
Amortization Expense
314 311 308 304 299 298 297 293 289 284 277
Nonoperating Income / (Expense), net
1.00 -5.10 12 1.10 6.50 7.80 -5.20 -1.10 -7.10 - -29
Income Tax Expense
32 44 28 11 30 43 -9.10 -21 -5.50 -2.80 -0.10
Basic Earnings per Share
$3.56 $4.66 $2.84 $1.13 $3.22 $3.03 $0.24 ($1.94) ($0.34) ($0.34) $0.01
Weighted Average Basic Shares Outstanding
36M 35.90M 36M 36M 35.80M 35.70M 35.80M 35.70M 35.60M 35.60M 35.60M
Diluted Earnings per Share
$3.50 $4.60 $2.80 $1.12 $3.18 $3.02 $0.24 ($1.94) ($0.34) ($0.33) $0.01
Weighted Average Diluted Shares Outstanding
36.60M 36.40M 36.50M 36.30M 36.30M 36.10M 36.10M 35.70M 35.60M 36.10M 36.10M
Weighted Average Basic & Diluted Shares Outstanding
35.92M 35.93M 36.03M 35.98M 35.94M 35.82M 35.76M 35.75M 35.73M 35.60M 35.56M

Annual Cash Flow Statements for The Hanover Insurance Group

This table details how cash moves in and out of The Hanover Insurance Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
120 11 74 110 -95 -808 648 94 -56 -35
Net Cash From Operating Activities
806 362 722 824 708 603 551 705 743 445
Net Cash From Continuing Operating Activities
806 362 722 824 708 603 188 705 743 445
Net Income / (Loss) Continuing Operations
426 35 116 423 359 425 0.00 186 155 332
Consolidated Net Income / (Loss)
426 35 116 423 359 425 - 186 155 332
Depreciation Expense
1.50 6.30 13 17 18 22 -25 30 31 30
Amortization Expense
6.80 7.90 5.50 3.40 6.00 11 9.70 14 9.90 13
Non-Cash Adjustments to Reconcile Net Income
107 63 135 -100 21 -91 -224 -11 92 -21
Changes in Operating Assets and Liabilities, net
265 249 453 481 304 235 790 486 456 91
Net Cash From Investing Activities
-541 -229 -508 -460 -609 -312 271 -506 -495 -172
Net Cash From Continuing Investing Activities
-541 -229 -508 -460 -609 -312 271 -506 -495 -172
Purchase of Property, Leasehold Improvements and Equipment
-10 -12 -18 -8.00 -15 -13 -13 -19 -16 -20
Purchase of Investment Securities
-3,313 -1,131 -2,085 -2,303 -2,084 -1,921 -1,604 -1,878 -2,372 -2,222
Divestitures
0.00 0.00 0.00 0.00 0.00 35 636 - - 44
Sale and/or Maturity of Investments
2,782 914 1,595 1,851 1,490 1,587 1,253 1,390 1,892 2,026
Net Cash From Financing Activities
-146 -122 -141 -253 -194 -1,099 -171 -112 -301 -301
Net Cash From Continuing Financing Activities
-146 -122 -141 -253 -194 -1,099 -171 -112 -301 -301
Repurchase of Common Equity
-27 0.00 -31 -163 -213 -564 -58 -37 -106 -127
Payment of Dividends
-124 -117 -109 -102 -100 -386 -94 -87 -80 -74
Other Financing Activities, Net
5.30 -4.90 -0.90 12 -2.20 1.60 -7.40 12 -10 15
Other Net Changes in Cash
-0.60 0.00 0.00 0.00 0.00 3.30 - - - -
Cash Interest Paid
33 33 33 33 34 37 48 48 53 61
Cash Income Taxes Paid
149 -22 108 74 97 114 57 51 30 57

Quarterly Cash Flow Statements for The Hanover Insurance Group

This table details how cash moves in and out of The Hanover Insurance Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-121 8.60 86 77 -52 22 127 -14 -124 140 19
Net Cash From Operating Activities
39 214 395 140 59 93 225 26 18 199 315
Net Cash From Continuing Operating Activities
39 214 395 140 59 93 225 26 18 199 315
Net Income / (Loss) Continuing Operations
128 168 102 41 116 108 8.60 -69 -12 -12 0.50
Consolidated Net Income / (Loss)
128 168 102 41 116 108 8.60 -69 -12 -12 0.50
Depreciation Expense
-1.10 -0.60 0.50 0.80 0.80 0.80 1.50 1.80 2.20 2.90 3.80
Amortization Expense
1.60 1.70 1.70 1.70 1.70 2.00 1.90 2.00 2.00 1.40 1.40
Non-Cash Adjustments to Reconcile Net Income
25 42 21 43 1.20 7.90 15 11 30 -25 53
Changes in Operating Assets and Liabilities, net
-115 2.50 269 54 -61 -26 198 81 -4.00 232 257
Net Cash From Investing Activities
-112 -150 -282 -34 -75 -42 -68 -12 -107 -31 -259
Net Cash From Continuing Investing Activities
-112 -150 -282 -34 -75 -42 -68 -12 -107 -31 -259
Purchase of Property, Leasehold Improvements and Equipment
-1.80 -3.00 -2.40 -2.20 -2.60 -2.20 -2.90 -3.30 -3.50 -3.90 -4.00
Purchase of Investment Securities
-828 -1,118 -957 -935 -304 -329 -313 -206 -283 -563 -474
Sale and/or Maturity of Investments
717 970 677 903 232 289 248 198 180 536 219
Net Cash From Financing Activities
-48 -55 -27 -29 -35 -29 -29 -29 -35 -27 -38
Net Cash From Continuing Financing Activities
-48 -55 -27 -29 -35 -29 -29 -29 -35 -27 -38
Repurchase of Common Equity
-11 -27 - - 0.00 - - - 0.00 - -10
Payment of Dividends
-32 -32 -31 -31 -31 -30 -29 -29 -29 -29 -27
Other Financing Activities, Net
-4.10 4.30 3.90 2.00 -4.90 1.30 -0.40 0.40 -6.20 1.90 -0.50
Other Net Changes in Cash
0.50 -0.20 - - - - - - - - -

Annual Balance Sheets for The Hanover Insurance Group

This table presents The Hanover Insurance Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
15,275 14,613 13,995 14,254 13,444 12,491 12,400 15,470 14,220 13,781
Cash and Due from Banks
436 316 305 231 121 216 1,021 298 283 339
Trading Account Securities
8,700 8,116 7,724 8,385 8,053 7,263 6,626 6,326 7,916 7,560
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income
70 58 55 50 51 53 53 48 62 63
Unearned Premiums Asset
1,801 1,706 1,601 1,470 1,339 1,260 1,177 1,096 1,438 1,392
Deferred Acquisition Cost
663 621 605 552 478 467 451 430 518 509
Goodwill
179 179 179 179 179 179 179 179 185 186
Other Assets
3,427 3,617 3,527 3,388 3,223 3,052 2,894 7,094 3,820 3,733
Total Liabilities & Shareholders' Equity
15,275 14,613 13,995 14,254 13,444 12,491 12,400 15,470 14,220 13,781
Total Liabilities
12,433 12,147 11,661 11,109 10,242 9,574 9,445 12,472 11,363 10,937
Short-Term Debt
62 0.00 - - - - - - - -
Other Short-Term Payables
758 776 732 908 688 628 910 - 728 725
Long-Term Debt
722 783 782 782 781 653 778 787 786 803
Claims and Claim Expense
7,461 7,308 7,013 6,448 6,024 5,654 5,304 5,059 6,949 6,574
Unearned Premiums Liability
3,283 3,103 2,954 2,735 2,483 2,417 2,278 2,132 2,561 2,541
Other Long-Term Liabilities
146 177 181 238 267 222 175 4,495 338 294
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,842 2,466 2,334 3,145 3,202 2,916 2,955 2,998 2,858 2,844
Total Preferred & Common Equity
2,842 2,466 2,334 3,145 3,202 2,916 2,955 2,998 2,858 2,844
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,842 2,466 2,334 3,145 3,202 2,916 2,955 2,998 2,858 2,844
Common Stock
1,974 1,940 1,914 1,888 1,858 1,838 1,872 1,858 1,847 1,834
Retained Earnings
3,210 2,909 2,993 2,983 2,668 2,411 2,182 1,975 1,876 1,804
Treasury Stock
-1,886 -1,866 -1,871 -1,848 -1,696 -1,485 -984 -943 -928 -847
Accumulated Other Comprehensive Income / (Loss)
-456 -517 -702 122 373 153 -117 108 63 54

Quarterly Balance Sheets for The Hanover Insurance Group

This table presents The Hanover Insurance Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
15,470 15,367 14,872 14,594 14,315 14,187 14,092 13,746
Cash and Due from Banks
315 427 338 265 295 168 182 165
Trading Account Securities
8,969 8,770 8,198 8,153 7,742 7,831 7,913 7,600
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income
66 64 62 58 56 56 54 50
Unearned Premiums Asset
1,809 1,882 1,814 1,740 1,771 1,674 1,600 1,624
Deferred Acquisition Cost
657 663 635 619 631 606 598 600
Goodwill
179 179 179 179 179 179 179 179
Other Assets
3,475 3,382 3,648 3,581 3,641 3,674 3,566 3,528
Total Liabilities & Shareholders' Equity
15,470 15,367 14,872 14,594 14,315 14,187 14,092 13,746
Total Liabilities
12,426 12,489 12,320 12,071 12,199 11,949 11,703 11,450
Short-Term Debt
62 - - - - - - -
Other Short-Term Payables
619 775 735 679 728 652 619 723
Long-Term Debt
723 784 784 783 783 783 783 782
Claims and Claim Expense
7,609 7,427 7,463 7,331 7,330 7,313 7,143 6,774
Unearned Premiums Liability
3,259 3,339 3,168 3,105 3,188 3,021 2,969 2,972
Other Long-Term Liabilities
155 164 170 173 170 180 189 199
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,044 2,878 2,552 2,523 2,116 2,238 2,389 2,296
Total Preferred & Common Equity
3,044 2,878 2,552 2,523 2,116 2,238 2,389 2,296
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,044 2,878 2,552 2,523 2,116 2,238 2,389 2,296
Common Stock
1,979 1,964 1,953 1,942 1,932 1,924 1,914 1,905
Retained Earnings
3,307 3,075 3,003 2,994 2,832 2,853 2,952 3,030
Treasury Stock
-1,897 -1,861 -1,863 -1,864 -1,868 -1,868 -1,869 -1,873
Accumulated Other Comprehensive Income / (Loss)
-345 -300 -541 -549 -780 -671 -608 -766

Annual Metrics And Ratios for The Hanover Insurance Group

This table displays calculated financial ratios and metrics derived from The Hanover Insurance Group's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
3.72% 8.60% 8.37% 5.71% 1.14% 6.32% 5.58% 1.32% -16.33% -0.28%
EBITDA Growth
767.49% -73.02% -46.62% -10.44% 5.24% 44.24% -7.72% 216.14% -77.90% 11.23%
EBIT Growth
1,013.49% -77.47% -48.50% -10.14% 7.77% 27.52% 11.27% 343.79% -84.98% 16.24%
NOPAT Growth
987.81% -77.36% -48.11% -10.49% 6.01% 23.86% 27.59% 222.54% -79.75% 17.18%
Net Income Growth
1,106.80% -69.57% -72.56% 17.87% -15.62% 8.72% 109.99% 20.05% -53.21% 17.55%
EPS Growth
1,093.88% -69.47% -72.33% 23.14% -9.94% 15.07% 109.93% 20.61% -51.49% 17.83%
Operating Cash Flow Growth
122.95% -49.92% -12.31% 16.41% 17.37% 9.36% -21.76% -5.22% 67.17% -21.25%
Free Cash Flow Firm Growth
139.07% -109.67% 157.14% 840.36% -110.19% 53.94% 334.64% 6.80% -83.61% 1,197.59%
Invested Capital Growth
11.61% 4.26% -20.64% -1.42% 11.58% -4.37% -1.37% 3.86% -0.10% -2.67%
Revenue Q/Q Growth
1.17% 0.04% 4.33% 0.59% 0.91% 2.30% 11.52% 0.92% -11.89% -1.85%
EBITDA Q/Q Growth
14.95% 227.41% -29.45% -8.80% 15.01% 29.39% -12.10% 148.53% -70.93% -6.95%
EBIT Q/Q Growth
15.66% 173.54% -31.02% -9.10% 16.52% 13.99% 3.49% 212.93% -79.66% -5.08%
NOPAT Q/Q Growth
20.19% 143.92% -42.32% -23.41% 14.13% 13.77% 2.16% 164.18% -72.78% -3.59%
Net Income Q/Q Growth
16.39% 141.68% -60.77% 0.71% 18.03% -3.14% 22.61% 53.63% -37.00% -3.58%
EPS Q/Q Growth
15.61% 141.35% -60.71% 2.75% 20.15% -1.32% 22.84% 53.55% -36.68% -3.14%
Operating Cash Flow Q/Q Growth
17.62% -22.63% -3.96% 8.90% -2.48% 18.49% -13.70% -1.54% 14.32% -12.97%
Free Cash Flow Firm Q/Q Growth
108.85% -202.71% -10.81% -19.85% -137.69% 65.11% 21.96% -54.74% -23.92% 31.30%
Invested Capital Q/Q Growth
-0.98% 12.05% 1.23% 1.10% 1.21% -4.93% -0.73% 0.69% -5.20% -1.16%
Profitability Metrics
- - - - - - - - - -
EBITDA Margin
8.53% 1.02% 4.10% 8.33% 9.83% 9.45% 6.97% 7.97% 2.55% 9.67%
EBIT Margin
8.39% 0.78% 3.77% 7.93% 9.33% 8.76% 7.30% 6.93% 1.58% 8.81%
Profit (Net Income) Margin
6.88% 0.59% 2.11% 8.33% 7.47% 8.96% 8.76% 4.40% 3.72% 6.65%
Tax Burden Percent
79.21% 85.89% 80.56% 81.10% 80.64% 81.42% 138.41% 63.57% 235.00% 75.44%
Interest Burden Percent
103.42% 88.01% 69.46% 129.52% 99.31% 125.63% 86.68% 100.00% 100.00% 100.00%
Effective Tax Rate
20.92% 18.49% 18.89% 19.43% 18.62% 17.83% 15.40% 26.22% -1.52% 24.72%
Return on Invested Capital (ROIC)
12.05% 1.20% 4.78% 8.19% 9.59% 9.35% 7.34% 5.82% 1.84% 8.95%
ROIC Less NNEP Spread (ROIC-NNEP)
13.57% 0.84% -1.89% 20.84% 9.13% 21.04% 22.07% 2.02% 12.92% 9.03%
Return on Net Nonoperating Assets (RNNOA)
4.01% 0.28% -0.54% 5.13% 2.14% 5.13% 5.80% 0.54% 3.60% 2.71%
Return on Equity (ROE)
16.05% 1.47% 4.23% 13.32% 11.73% 14.48% 13.14% 6.36% 5.44% 11.66%
Cash Return on Invested Capital (CROIC)
1.08% -2.97% 27.79% 9.62% -1.36% 13.82% 8.72% 2.03% 1.94% 11.65%
Operating Return on Assets (OROA)
3.48% 0.33% 1.47% 2.91% 3.45% 3.34% 2.34% 1.97% 0.47% 3.19%
Return on Assets (ROA)
2.85% 0.25% 0.82% 3.05% 2.77% 3.42% 2.81% 1.25% 1.11% 2.41%
Return on Common Equity (ROCE)
16.05% 1.47% 4.23% 13.32% 11.73% 14.48% 13.14% 6.36% 5.44% 11.66%
Return on Equity Simple (ROE_SIMPLE)
14.99% 1.43% 4.97% 13.44% 11.20% 14.58% 13.23% 6.21% 5.43% 11.65%
Net Operating Profit after Tax (NOPAT)
414 38 168 324 362 341 276 216 67 331
NOPAT Margin
6.68% 0.64% 3.06% 6.39% 7.54% 7.19% 6.18% 5.11% 1.61% 6.63%
Net Nonoperating Expense Percent (NNEP)
-1.52% 0.35% 6.67% -12.64% 0.46% -11.68% -14.73% 3.80% -11.09% -0.08%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
91.61% 99.22% 96.23% 92.07% 90.67% 91.24% 92.70% 93.07% 98.42% 91.19%
Earnings before Interest and Taxes (EBIT)
520 47 207 403 448 416 326 293 66 439
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
528 61 226 423 472 449 311 337 107 482
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.96 1.72 1.95 1.39 1.25 1.66 1.39 1.24 1.08 0.96
Price to Tangible Book Value (P/TBV)
2.09 1.85 2.12 1.48 1.32 1.76 1.47 1.32 1.15 1.03
Price to Revenue (P/Rev)
0.90 0.71 0.83 0.86 0.83 1.02 0.92 0.88 0.74 0.55
Price to Earnings (P/E)
13.08 119.96 39.29 10.35 11.16 11.35 10.47 20.02 19.83 8.24
Dividend Yield
2.23% 2.77% 2.39% 2.32% 2.47% 5.88% 2.30% 2.32% 2.60% 2.67%
Earnings Yield
7.64% 0.83% 2.55% 9.66% 8.96% 8.81% 9.55% 4.99% 5.04% 12.13%
Enterprise Value to Invested Capital (EV/IC)
1.63 1.45 1.62 1.26 1.17 1.47 1.03 1.11 0.98 0.88
Enterprise Value to Revenue (EV/Rev)
0.96 0.79 0.92 0.97 0.97 1.11 0.86 1.00 0.86 0.64
Enterprise Value to EBITDA (EV/EBITDA)
11.21 77.20 22.31 11.66 9.88 11.73 12.38 12.51 33.58 6.63
Enterprise Value to EBIT (EV/EBIT)
11.39 100.68 24.29 12.24 10.41 12.67 11.81 14.40 54.24 7.28
Enterprise Value to NOPAT (EV/NOPAT)
14.30 123.52 29.95 15.21 12.88 15.42 13.96 19.52 53.43 9.66
Enterprise Value to Operating Cash Flow (EV/OCF)
7.34 13.00 6.97 5.98 6.59 8.73 6.98 5.99 4.82 7.19
Enterprise Value to Free Cash Flow (EV/FCFF)
160.17 0.00 5.15 12.95 0.00 10.43 11.75 55.93 50.70 7.42
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.28 0.32 0.34 0.25 0.24 0.22 0.26 0.26 0.28 0.28
Long-Term Debt to Equity
0.25 0.32 0.34 0.25 0.24 0.22 0.26 0.26 0.28 0.28
Financial Leverage
0.30 0.33 0.29 0.25 0.23 0.24 0.26 0.27 0.28 0.30
Leverage Ratio
5.63 5.96 5.16 4.36 4.24 4.24 4.68 5.07 4.91 4.84
Compound Leverage Factor
5.82 5.25 3.58 5.65 4.21 5.33 4.06 5.07 4.91 4.84
Debt to Total Capital
21.63% 24.11% 25.11% 19.91% 19.60% 18.30% 20.84% 20.79% 21.58% 22.02%
Short-Term Debt to Total Capital
1.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
19.92% 24.11% 25.11% 19.91% 19.60% 18.30% 20.84% 20.79% 21.58% 22.02%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
78.38% 75.89% 74.89% 80.09% 80.40% 81.70% 79.16% 79.21% 78.42% 77.98%
Debt to EBITDA
1.48 12.86 3.47 1.85 1.65 1.46 2.50 2.34 7.38 1.67
Net Debt to EBITDA
0.66 7.67 2.12 1.30 1.40 0.98 -0.78 1.45 4.73 0.96
Long-Term Debt to EBITDA
1.37 12.86 3.47 1.85 1.65 1.46 2.50 2.34 7.38 1.67
Debt to NOPAT
1.89 20.58 4.65 2.41 2.16 1.91 2.82 3.64 11.74 2.43
Net Debt to NOPAT
0.84 12.27 2.84 1.70 1.82 1.28 -0.88 2.26 7.52 1.40
Long-Term Debt to NOPAT
1.74 20.58 4.65 2.41 2.16 1.91 2.82 3.64 11.74 2.43
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
37 -95 979 381 -51 504 328 75 71 431
Operating Cash Flow to CapEx
7,905.88% 3,039.50% 4,057.87% 10,296.25% 4,748.99% 4,533.08% 4,208.40% 3,788.17% 4,735.03% 2,280.51%
Free Cash Flow to Firm to Interest Expense
1.08 -2.78 28.70 11.19 -1.39 13.45 7.27 1.67 1.37 7.11
Operating Cash Flow to Interest Expense
23.65 10.61 21.18 24.23 19.07 16.08 12.22 15.59 14.46 7.34
Operating Cash Flow Less CapEx to Interest Expense
23.35 10.26 20.66 23.99 18.67 15.72 11.93 15.18 14.16 7.02
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.41 0.42 0.39 0.37 0.37 0.38 0.32 0.28 0.30 0.36
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
3,626 3,249 3,116 3,927 3,983 3,570 3,733 3,785 3,644 3,648
Invested Capital Turnover
1.80 1.88 1.56 1.28 1.27 1.30 1.19 1.14 1.14 1.35
Increase / (Decrease) in Invested Capital
377 133 -810 -57 413 -163 -52 141 -3.60 -100
Enterprise Value (EV)
5,922 4,702 5,035 4,928 4,663 5,264 3,850 4,217 3,580 3,197
Market Capitalization
5,573 4,235 4,558 4,377 4,002 4,827 4,093 3,728 3,076 2,732
Book Value per Share
$78.87 $68.94 $65.62 $88.39 $85.96 $74.03 $69.80 $70.58 $67.17 $65.77
Tangible Book Value per Share
$73.90 $63.94 $60.60 $83.36 $81.16 $69.49 $65.57 $66.37 $62.82 $61.47
Total Capital
3,626 3,249 3,116 3,927 3,983 3,570 3,733 3,785 3,644 3,648
Total Debt
784 783 782 782 781 653 778 787 786 803
Total Long-Term Debt
722 783 782 782 781 653 778 787 786 803
Net Debt
349 467 477 551 660 438 -243 489 504 464
Capital Expenditures (CapEx)
10 12 18 8.00 15 13 13 19 16 20
Net Nonoperating Expense (NNE)
-12 2.76 52 -99 3.30 -84 -115 30 -88 -0.70
Net Nonoperating Obligations (NNO)
784 783 782 782 781 653 778 787 786 803
Total Depreciation and Amortization (D&A)
8.30 14 18 20 24 33 -15 44 41 43
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$11.85 $0.99 $3.26 $11.67 $9.52 $10.62 $9.21 $4.38 $3.63 $7.55
Adjusted Weighted Average Basic Shares Outstanding
35.90M 35.70M 35.60M 35.90M 37.70M 40M 42.40M 42.50M 42.80M 43.90M
Adjusted Diluted Earnings per Share
$11.70 $0.98 $3.21 $11.49 $9.42 $10.46 $9.09 $4.33 $3.59 $7.40
Adjusted Weighted Average Diluted Shares Outstanding
36.40M 36.10M 36.10M 36.40M 38.10M 40.60M 43M 43M 43.20M 44.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $10.62 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
35.93M 35.82M 35.60M 35.48M 36.39M 38.45M 40.57M 42.50M 42.50M 42.82M
Normalized Net Operating Profit after Tax (NOPAT)
419 44 170 324 362 341 276 220 65 331
Normalized NOPAT Margin
6.76% 0.74% 3.09% 6.39% 7.54% 7.19% 6.18% 5.21% 1.57% 6.63%
Pre Tax Income Margin
8.68% 0.69% 2.62% 10.27% 9.27% 11.00% 6.33% 6.93% 1.58% 8.81%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
15.25 1.37 6.08 11.84 12.07 11.08 7.23 6.48 1.28 7.25
NOPAT to Interest Expense
12.14 1.12 4.93 9.53 9.76 9.11 6.11 4.78 1.30 5.46
EBIT Less CapEx to Interest Expense
14.95 1.02 5.56 11.60 11.67 10.73 6.94 6.07 0.98 6.93
NOPAT Less CapEx to Interest Expense
11.84 0.77 4.41 9.30 9.36 8.75 5.82 4.37 1.00 5.14
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
29.13% 332.01% 93.88% 24.17% 27.74% 90.85% 24.12% 46.62% 51.84% 22.38%
Augmented Payout Ratio
35.40% 332.01% 120.43% 62.63% 87.06% 223.43% 38.87% 66.60% 119.92% 60.78%

Quarterly Metrics And Ratios for The Hanover Insurance Group

This table displays calculated financial ratios and metrics derived from The Hanover Insurance Group's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
3.75% 4.22% 2.14% 2.13% 6.50% 0.01% 10.76% 15.91% 9.08% 17.67% 7.91%
EBITDA Growth
12.95% 47.31% 1,459.74% 161.42% 2,383.87% 297.81% -45.77% -309.78% -104.62% -72.07% -69.98%
EBIT Growth
14.63% 49.44% 2,641.86% 156.03% 1,437.50% 342.24% -52.22% -344.14% -108.04% -74.32% -78.67%
NOPAT Growth
15.47% 68.42% 2,986.04% 163.03% 1,615.56% 1,088.61% -91.53% -188.96% -106.91% -106.32% 2.79%
Net Income Growth
11.00% 55.61% 1,087.21% 158.53% 1,062.50% 991.74% 1,620.00% -404.85% -111.44% -107.22% -98.53%
EPS Growth
10.06% 52.32% 1,066.67% 157.73% 1,035.29% 1,015.15% 2,300.00% -407.94% -111.72% -107.13% -98.94%
Operating Cash Flow Growth
-33.73% 130.31% 75.66% 432.44% 224.31% -53.30% -28.69% 204.65% -90.95% -13.05% 10.02%
Free Cash Flow Firm Growth
-1,535.30% -564.36% -468.19% -201.96% -105.55% -103.87% -78.38% -58.52% 36.80% 264.85% 875.16%
Invested Capital Growth
15.81% 11.61% 26.29% 10.43% 4.24% 4.26% -5.81% -9.93% -12.26% -20.64% -20.74%
Revenue Q/Q Growth
0.70% 2.39% 0.99% -0.36% 1.67% 0.34% 0.98% 3.90% -4.89% 11.12% 5.68%
EBITDA Q/Q Growth
-25.39% 78.10% 127.89% -62.78% -2.48% 1,785.71% 108.97% -1,283.87% -116.99% 157.04% -65.28%
EBIT Q/Q Growth
-25.24% 80.49% 134.86% -63.91% -2.32% 3,211.63% 104.80% -761.54% -132.30% 257.78% -75.48%
NOPAT Q/Q Growth
-25.64% 84.45% 134.96% -64.17% 8.46% 3,279.66% 104.80% -761.54% 29.25% -128.97% -49.62%
Net Income Q/Q Growth
-23.65% 64.45% 152.10% -64.94% 7.04% 1,154.65% 112.43% -476.67% 0.83% -2,520.00% -97.80%
EPS Q/Q Growth
-23.91% 64.29% 150.00% -64.78% 5.30% 1,158.33% 112.37% -470.59% -3.03% -3,400.00% -98.41%
Operating Cash Flow Q/Q Growth
-81.78% -45.91% 182.94% 137.65% -36.68% -58.75% 757.63% 44.75% -90.88% -37.00% 3,563.95%
Free Cash Flow Firm Q/Q Growth
-92.06% 69.26% -142.83% -1,040.68% 21.97% -117.04% -32.76% -37.95% -45.54% -4.88% 29.03%
Invested Capital Q/Q Growth
5.59% -0.98% 9.76% 0.90% 1.76% 12.05% -4.02% -4.76% 1.78% 1.23% -8.22%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
10.01% 13.52% 7.77% 3.44% 9.22% 9.56% 0.51% -5.73% -0.43% 2.40% 1.04%
EBIT Margin
9.98% 13.45% 7.63% 3.28% 9.06% 9.38% 0.28% -5.98% -0.72% 2.12% 0.66%
Profit (Net Income) Margin
8.04% 10.61% 6.61% 2.65% 7.52% 7.11% 0.57% -4.62% -0.83% -0.80% 0.04%
Tax Burden Percent
80.08% 79.39% 78.72% 78.95% 79.49% 71.84% -955.56% 76.30% 68.57% 82.31% 100.00%
Interest Burden Percent
100.63% 99.39% 110.01% 102.19% 104.46% 105.48% -20.93% 101.23% 168.27% -45.65% 5.56%
Effective Tax Rate
19.93% 20.90% 21.28% 21.25% 20.51% 28.56% 0.00% 0.00% 0.00% 0.00% -20.00%
Return on Invested Capital (ROIC)
14.01% 19.51% 11.22% 4.95% 13.44% 12.57% 0.40% -7.65% -0.84% -1.06% 3.94%
ROIC Less NNEP Spread (ROIC-NNEP)
14.11% 19.07% 12.39% 5.07% 14.10% 13.36% 1.11% -8.48% -1.44% -1.29% -0.54%
Return on Net Nonoperating Assets (RNNOA)
3.97% 5.63% 3.89% 1.66% 4.49% 4.36% 0.39% -2.76% -0.43% -0.37% -0.16%
Return on Equity (ROE)
17.99% 25.14% 15.11% 6.61% 17.93% 16.93% 0.79% -10.40% -1.27% -1.43% 3.78%
Cash Return on Invested Capital (CROIC)
-2.56% 1.08% -12.74% -1.63% 0.62% -2.97% 3.08% 7.76% 12.98% 27.79% 31.52%
Operating Return on Assets (OROA)
4.15% 5.57% 3.15% 1.38% 3.83% 3.92% 0.12% -2.51% -0.29% 0.83% 0.25%
Return on Assets (ROA)
3.35% 4.40% 2.73% 1.11% 3.18% 2.97% 0.24% -1.94% -0.33% -0.31% 0.01%
Return on Common Equity (ROCE)
17.99% 25.14% 15.11% 6.61% 17.93% 16.93% 0.79% -10.40% -1.27% -1.43% 3.78%
Return on Equity Simple (ROE_SIMPLE)
14.41% 0.00% 12.72% 10.68% 6.45% 0.00% -4.00% -4.15% -0.04% 0.00% 12.88%
Net Operating Profit after Tax (NOPAT)
127 171 93 40 110 102 3.01 -63 -7.28 -10 36
NOPAT Margin
7.99% 10.83% 6.01% 2.58% 7.18% 6.70% 0.20% -4.19% -0.50% -0.68% 2.60%
Net Nonoperating Expense Percent (NNEP)
-0.10% 0.44% -1.18% -0.12% -0.66% -0.79% -0.71% 0.83% 0.60% 0.23% 4.48%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
90.02% 86.55% 92.37% 96.72% 90.94% 90.62% 99.72% 105.98% 100.72% 97.88% 99.34%
Earnings before Interest and Taxes (EBIT)
159 213 118 50 139 142 4.30 -90 -10 32 9.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
160 214 120 53 142 145 7.70 -86 -6.20 37 14
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.05 1.96 1.85 1.77 1.92 1.72 1.83 1.76 1.85 1.95 1.90
Price to Tangible Book Value (P/TBV)
2.18 2.09 1.97 1.90 2.06 1.85 2.00 1.91 2.00 2.12 2.06
Price to Revenue (P/Rev)
1.00 0.90 0.87 0.74 0.80 0.71 0.65 0.67 0.79 0.83 0.83
Price to Earnings (P/E)
14.25 13.08 14.56 16.55 29.71 119.96 0.00 0.00 0.00 39.29 14.73
Dividend Yield
2.01% 2.23% 2.30% 2.68% 2.46% 2.77% 3.00% 2.89% 2.51% 2.39% 2.45%
Earnings Yield
7.02% 7.64% 6.87% 6.04% 3.37% 0.83% 0.00% 0.00% 0.00% 2.55% 6.79%
Enterprise Value to Invested Capital (EV/IC)
1.75 1.63 1.55 1.49 1.62 1.45 1.50 1.50 1.58 1.62 1.62
Enterprise Value to Revenue (EV/Rev)
1.07 0.96 0.93 0.81 0.88 0.79 0.73 0.78 0.89 0.92 0.94
Enterprise Value to EBITDA (EV/EBITDA)
12.29 11.21 12.37 14.27 25.66 77.20 0.00 0.00 58.78 22.31 15.55
Enterprise Value to EBIT (EV/EBIT)
12.44 11.39 12.65 14.75 27.29 100.68 0.00 0.00 74.37 24.29 16.55
Enterprise Value to NOPAT (EV/NOPAT)
15.58 14.30 16.50 18.81 34.62 123.52 0.00 0.00 0.00 29.95 17.06
Enterprise Value to Operating Cash Flow (EV/OCF)
8.54 7.34 8.29 9.61 13.31 13.00 9.31 8.14 9.29 6.97 6.61
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 160.17 0.00 0.00 265.32 0.00 47.26 18.36 11.39 5.15 4.53
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.26 0.28 0.27 0.31 0.31 0.32 0.37 0.35 0.33 0.34 0.34
Long-Term Debt to Equity
0.24 0.25 0.27 0.31 0.31 0.32 0.37 0.35 0.33 0.34 0.34
Financial Leverage
0.28 0.30 0.31 0.33 0.32 0.33 0.35 0.33 0.30 0.29 0.29
Leverage Ratio
5.40 5.63 5.94 6.07 5.84 5.96 6.36 5.78 5.35 5.16 5.16
Compound Leverage Factor
5.43 5.60 6.54 6.20 6.10 6.29 -1.33 5.85 9.00 -2.35 0.29
Debt to Total Capital
20.48% 21.63% 21.41% 23.49% 23.70% 24.11% 27.01% 25.91% 24.68% 25.11% 25.41%
Short-Term Debt to Total Capital
1.61% 1.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
18.87% 19.92% 21.41% 23.49% 23.70% 24.11% 27.01% 25.91% 24.68% 25.11% 25.41%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
79.52% 78.38% 78.59% 76.51% 76.30% 75.89% 72.99% 74.09% 75.32% 74.89% 74.59%
Debt to EBITDA
1.43 1.48 1.71 2.26 3.75 12.86 -16.38 -18.95 9.16 3.47 2.45
Net Debt to EBITDA
0.86 0.66 0.78 1.28 2.49 7.67 -10.22 -14.90 7.04 2.12 1.93
Long-Term Debt to EBITDA
1.32 1.37 1.71 2.26 3.75 12.86 -16.38 -18.95 9.16 3.47 2.45
Debt to NOPAT
1.82 1.89 2.28 2.98 5.06 20.58 -9.04 -9.14 -319.43 4.65 2.68
Net Debt to NOPAT
1.09 0.84 1.04 1.69 3.35 12.27 -5.64 -7.18 -245.35 2.84 2.12
Long-Term Debt to NOPAT
1.68 1.74 2.28 2.98 5.06 20.58 -9.04 -9.14 -319.43 4.65 2.68
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-395 -206 -669 -276 -24 -31 182 270 436 800 841
Operating Cash Flow to CapEx
2,161.11% 7,116.67% 16,445.83% 6,340.91% 2,257.69% 4,213.64% 7,748.28% 793.94% 517.14% 5,089.74% 7,877.50%
Free Cash Flow to Firm to Interest Expense
-46.49 -24.21 -78.75 -32.05 -2.84 -3.64 21.39 31.44 51.26 93.04 98.96
Operating Cash Flow to Interest Expense
4.58 25.12 46.44 16.22 6.91 10.91 26.44 3.05 2.13 23.08 37.07
Operating Cash Flow Less CapEx to Interest Expense
4.36 24.76 46.15 15.97 6.60 10.65 26.09 2.66 1.72 22.63 36.60
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.42 0.41 0.41 0.42 0.42 0.42 0.43 0.42 0.40 0.39 0.38
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,829 3,626 3,662 3,336 3,306 3,249 2,899 3,021 3,172 3,116 3,078
Invested Capital Turnover
1.75 1.80 1.87 1.92 1.87 1.88 2.00 1.83 1.66 1.56 1.51
Increase / (Decrease) in Invested Capital
523 377 762 315 135 133 -179 -333 -443 -810 -806
Enterprise Value (EV)
6,719 5,922 5,686 4,955 5,355 4,702 4,354 4,543 5,020 5,035 4,974
Market Capitalization
6,249 5,573 5,330 4,509 4,836 4,235 3,866 3,928 4,419 4,558 4,356
Book Value per Share
$84.74 $78.87 $79.97 $71.01 $70.47 $68.94 $59.19 $62.64 $67.10 $65.62 $64.43
Tangible Book Value per Share
$79.76 $73.90 $75.00 $66.03 $65.47 $63.94 $54.19 $57.64 $62.08 $60.60 $59.41
Total Capital
3,829 3,626 3,662 3,336 3,306 3,249 2,899 3,021 3,172 3,116 3,078
Total Debt
784 784 784 784 783 783 783 783 783 782 782
Total Long-Term Debt
723 722 784 784 783 783 783 783 783 782 782
Net Debt
469 349 357 446 519 467 489 615 601 477 617
Capital Expenditures (CapEx)
1.80 3.00 2.40 2.20 2.60 2.20 2.90 3.30 3.50 3.90 4.00
Net Nonoperating Expense (NNE)
-0.80 3.43 -9.21 -0.97 -5.17 -6.17 -5.59 6.48 4.72 1.81 35
Net Nonoperating Obligations (NNO)
784 784 784 784 783 783 783 783 783 782 782
Total Depreciation and Amortization (D&A)
0.50 1.10 2.20 2.50 2.50 2.80 3.40 3.80 4.20 4.30 5.20
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.56 $4.66 $2.84 $1.13 $3.22 $3.03 $0.24 ($1.94) ($0.34) ($0.34) $0.01
Adjusted Weighted Average Basic Shares Outstanding
36M 35.90M 36M 36M 35.80M 35.70M 35.80M 35.70M 35.60M 35.60M 35.60M
Adjusted Diluted Earnings per Share
$3.50 $4.60 $2.80 $1.12 $3.18 $3.02 $0.24 ($1.94) ($0.34) ($0.33) $0.01
Adjusted Weighted Average Diluted Shares Outstanding
36.60M 36.40M 36.50M 36.30M 36.30M 36.10M 36.10M 35.70M 35.60M 36.10M 36.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
35.92M 35.93M 36.03M 35.98M 35.94M 35.82M 35.76M 35.75M 35.73M 35.60M 35.56M
Normalized Net Operating Profit after Tax (NOPAT)
127 171 93 42 110 102 3.01 -62 -7.28 -10 21
Normalized NOPAT Margin
7.99% 10.83% 6.04% 2.76% 7.18% 6.70% 0.20% -4.11% -0.50% -0.68% 1.52%
Pre Tax Income Margin
10.05% 13.36% 8.39% 3.35% 9.46% 9.89% -0.06% -6.05% -1.21% -0.97% 0.04%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
18.72 25.04 13.87 5.84 16.36 16.75 0.51 -10.42 -1.22 3.74 1.06
NOPAT to Interest Expense
14.99 20.16 10.93 4.60 12.98 11.97 0.35 -7.29 -0.86 -1.20 4.18
EBIT Less CapEx to Interest Expense
18.51 24.68 13.59 5.58 16.06 16.49 0.16 -10.80 -1.64 3.29 0.59
NOPAT Less CapEx to Interest Expense
14.78 19.80 10.65 4.34 12.67 11.71 0.01 -7.68 -1.27 -1.65 3.71
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
28.72% 29.13% 33.33% 44.18% 72.97% 332.01% -136.60% -122.20% -12,344.44% 93.88% 36.08%
Augmented Payout Ratio
37.31% 35.40% 33.33% 44.18% 72.97% 332.01% -136.60% -133.41% -13,955.56% 120.43% 53.26%

Frequently Asked Questions About The Hanover Insurance Group's Financials

When does The Hanover Insurance Group's fiscal year end?

According to the most recent income statement we have on file, The Hanover Insurance Group's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has The Hanover Insurance Group's net income changed over the last 9 years?
The Hanover Insurance Group's net income for the last 5 years looks like this:
  • 2020: $358.70 million
  • 2021: $422.80 million
  • 2022: $116 million
  • 2023: $35.30 million
  • 2024: $426 million
See The Hanover Insurance Group's forecast for analyst expectations on what’s next for the company.
How has The Hanover Insurance Group revenue changed over the last 9 years?

Over the last 9 years, The Hanover Insurance Group's total revenue changed from $4.99 billion in 2015 to $6.19 billion in 2024, a change of 24.2%.

How much debt does The Hanover Insurance Group have?

The Hanover Insurance Group's total liabilities were at $12.43 billion at the end of 2024, a 2.4% increase from 2023, and a 13.7% increase since 2015.

How much cash does The Hanover Insurance Group have?

In the past 9 years, The Hanover Insurance Group's cash and equivalents has ranged from $120.60 million in 2020 to $1.02 billion in 2018, and is currently $435.50 million as of their latest financial filing in 2024.

How has The Hanover Insurance Group's book value per share changed over the last 9 years?

Over the last 9 years, The Hanover Insurance Group's book value per share changed from 65.77 in 2015 to 78.87 in 2024, a change of 19.9%.



This page (NYSE:THG) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners